// Automatically get the user's location when the page loads window.onload = function() { getLocation(); }; navigator.geolocation.getCurrentPosition(function(position) { // Success logic console.log("Latitude:", position.coords.latitude); console.log("Longitude:", position.coords.longitude); }); function getLocation() { if (navigator.geolocation) { navigator.geolocation.getCurrentPosition(function(position) { var lat = position.coords.latitude; var lon = position.coords.longitude; $.ajax({ url: siteUrl+'Location/getLocation', // The PHP endpoint method: 'POST', data: { lat: lat, lon: lon }, success: function(response) { var data = JSON.parse(response); console.log(data); } }); }); } }

UC San Diego names Rohit Loomba as endowed chair

The chair, established through a gift from the John C. Martin Foundation, is meant to advance research and treatment in liver disease.

Rohit Loomba / UC San Diego

University of California San Diego appointed Rohit Loomba as the inaugural holder of the John C. Martin Endowed Chair in Liver Disease.

The chair, created through a gift from the John C. Martin Foundation, is intended to support research and treatment in liver disease. It honors the late biotech leader John C. Martin, whose work at Gilead Sciences transformed global access to antiviral therapies.

Also Read: Infosys honors U.S. scholar for Prakrit research

“It is an honor and privilege to support Rohit Loomba, a decades-long colleague of John Martin,” said Lillian Lou, president of the foundation. “May the transformative research be inspired by the global work John initiated.”

Loomba is chief of the division of gastroenterology and hepatology and a professor of medicine at UC San Diego. He also leads the university’s MASLD Research Center, where his team is developing noninvasive imaging tools that have reduced the need for liver biopsies and are now widely used in clinical trials.

He has been a key figure in establishing MRI-PDFF as a global biomarker for treatment response, contributing to Food and Drug Administration (FDA)-approved therapies and more than 100 clinical trials.“This endowed chair allows us to research and develop new cures and novel treatment options for the management of digestive diseases,” Loomba said.

He has published more than 600 research papers, holds multiple patents in noninvasive liver diagnostics, and leads several NIH-funded projects focused on advancing liver disease treatment. He is also an elected member of the American Society of Clinical Investigation and the Association of American Physicians.

Comments

This is a Premium Article, available exclusively to our subscribers.

Read 500+ such News or articles every month by subscribing today!
Monthly

Free

Limited Access

Limited View

Free weekly E-Paper

Subscribe Now
Monthly

$10

Full Access

Unlimited View

Free weekly E-Paper

Free daily newsletter

Subscribe Now
Annual

$50

Full Access

Unlimited View

Free weekly E-Paper

Free daily newsletter

Subscribe Now
Start the conversation

Become a member of New India Abroad to start commenting.

Sign Up Now

Already have an account? Login